Page 1 of Clinical Trials for GVAX, 19 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Last Updated: May 18, 2012
Condition(s): Pancreatic Cancer
2
Recruiting
Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
Last Updated: September 20, 2011
Condition(s): Melanoma
3
Terminated
Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer
Last Updated: January 10, 2012
Condition(s): Prostate Cancer
4
Active, not recruiting
GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
Last Updated: February 23, 2009
Condition(s): Prostate Cancer
5
Completed
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)
Last Updated: August 30, 2005
Condition(s): Prostate Cancer
6
Completed
Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
Last Updated: December 18, 2007
Condition(s): Prostate Cancer
7
Completed
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer
Last Updated: August 30, 2005
Condition(s): Prostate Cancer
8
Completed
Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)
Last Updated: August 30, 2005
Condition(s): Prostate Cancer
9
Completed
Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia
Last Updated: December 18, 2007
Condition(s): Acute Myelogenous Leukemia
10
Terminated
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Last Updated: November 3, 2008
Condition(s): Prostate Cancer
11
Completed
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
Last Updated: March 15, 2012
Condition(s): Myelodysplastic Syndrome RAEB-I or RAEB-II; Refractory Acute Myeloid Leukemia; Refractory CML Myeloid Blast Crisis
12
Terminated
Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
Last Updated: September 19, 2008
Condition(s): Prostate Cancer
13
Not yet recruiting
Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas
Last Updated: May 9, 2012
Condition(s): Pancreatic Cancer
14
Active, not recruiting
S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
Last Updated: July 18, 2011
Condition(s): Lung Cancer
15
Active, not recruiting
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
Last Updated: October 30, 2009
Condition(s): Sarcoma, Clear Cell; Sarcoma, Alveolar Soft Part; Renal Cell Carcinoma; Melanoma
16
Recruiting
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Last Updated: January 27, 2012
Condition(s): Pancreatic Cancer
17
Not yet recruiting
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Last Updated: February 6, 2009
Condition(s): Prostate Cancer
18
Completed
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Last Updated: September 8, 2011
Condition(s): Pancreatic Cancer
19
Completed
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
Last Updated: December 18, 2007
Condition(s): Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=GVAX

Page 1 of Clinical Trials for GVAX, 19 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About